Thank you @curecc for highlighting our poster describing FGFR2b as a promising cell surface target in cholangiocarcinoma at #AACR26! We hope to expand tx options for CCA patients. I am very grateful for the for the mentorship of @ShuklaSachet and @JavleMilind!